0.00
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Quick-Med Technologies
Its shares trade under the ticker QMDT. It has been listed since 4 September 2002. In the fiscal year to 30 June 2013, it reported revenue of $928,493 and a net loss of $713,073. At that date it held total assets of $723,243 and shareholders' equity of −$9.1m.
Quick-Med Technologies, Inc. is a life sciences company which engages in developing and commercializing proprietary, broad-based technologies for the consumer and healthcare markets. The company is headquartered in Boca Raton, Florida. The company went IPO on 2002-09-04. The firm is focused on developing technologies for infection prevention and control in the consumer and healthcare markets. The firm offers four technologies, including NIMBUS, Stay Fresh, NimbuDerm and MultiStat. NIMBUS is a family of advanced polymers bioengineered for antimicrobial, hemostatic, and other properties that can be used in a range of medical device applications, including wound dressings, medical textiles, catheters, tubing, films and coatings. Stay Fresh is a chemical formulation for textiles with a durable antimicrobial agent effective against an array of bacteria even after numerous laundering cycles. NimbuDerm is a copolymer for application as a persistent hand sanitizer with long lasting protection against germs. MultiStat is a family of patented methods and compounds shown to be effective in skin therapy applications.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 4 Sept 2002
- Employees
- 6
- Website
- quickmedtech.com ↗
Leadership
Pay as last reported
- Dr. Gregory SchultzChairman of the Board, since 2000
- Dr. Bernd LiesenfeldPresident, Director, since 2012$126,125
- Paul JenssenChief Financial Officer, Director, since 2013$80,338
- Gerald OldermanDirector, since 1997$127,275
- Dale BergmanIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Quick-Med Technologies Inc has a strong portfolio of innovative and unique medical technologies that provide solutions for various healthcare challenges. Their products have been well-received in the market.
- The company has a talented and experienced team of professionals who possess extensive knowledge and expertise in the medical field. This allows Quick-Med Technologies to stay at the forefront of scientific advancements and adapt to changing trends.
Weaknesses
- Quick-Med Technologies Inc relies heavily on a limited number of products for their revenue generation. This high dependency poses a risk in case of any market fluctuations or decline in demand for their existing offerings.
- The company faces stiff competition from other medical technology firms, which may have similar or alternative solutions. This puts pressure on Quick-Med Technologies to continuously innovate and differentiate themselves from competitors.
Opportunities
- Quick-Med Technologies Inc can explore expansion into new geographic markets to tap into currently untapped customer segments. Additionally, they can identify and develop new products or enhancements to their existing offerings to meet the evolving needs of the healthcare industry.
- The increasing demand for advanced medical technologies presents an opportunity for Quick-Med Technologies to grow their market share and increase their customer base. They can leverage their expertise to address emerging challenges and seize new possibilities.
Threats
- Rapid technological advancements in the medical field may render Quick-Med Technologies' existing products obsolete if not updated or improved regularly. Thus, they need to stay vigilant and invest in research and development to remain competitive.
- Regulatory changes and compliance requirements pose a threat to Quick-Med Technologies' operations. Any non-compliance issues can result in penalties and damage their reputation.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.